Alkermes to Present at the 41st Annual J.P. Morgan Healthcare Conference

<br /> Alkermes to Present at the 41st Annual J.P. Morgan Healthcare Conference<br />

PR Newswire

DUBLIN

,

Dec. 28, 2022

/PRNewswire/ —

Alkermes plc

(Nasdaq: ALKS) announced today that its Chief Executive Officer,

Richard Pops

, will provide a corporate overview and update at the 41
^st
Annual J.P. Morgan Healthcare Conference. The presentation will take place on

Wednesday, Jan. 11, 2023

at

11:15 a.m. PST

(

2:15 p.m. EST

/

7:15 p.m. GMT

), followed by a question and answer session. The live webcast may be accessed under the Investors tab on

www.alkermes.com

and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at

www.alkermes.com

.

Contact:

Jamie Bernard

Investor Relations

+1 781 873-2402